Cover Image
Market Research Report

Analyzing Generics Market in India 2017

Published by Aruvian's R'search Product code 482465
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
Analyzing Generics Market in India 2017
Published: March 1, 2017 Content info: 100 Pages
Description

The Indian pharmaceutical industry is the third biggest in the world in terms of volume. The government has actively encouraged the growth of drug manufacturing within the country and has been providing many incentives to leading global manufacturers to set up their production hubs in India. Mumbai, Hyderabad, Bangalore, Ahmedabad and Visakhapatnam are some of the leading pharmaceutical hubs in the country.

The Indian generics industry has similarly experienced robust growth in the last couple of years and generics account for over 96% of the overall pharmaceutical market in India. The Indian Government's 'Pharma Vision 2020' has been a major factor towards the growth of the generics segment in the country.

Aruvian Research presents Analyzing Generics Market in India 2017 - a comprehensive coverage of the Indian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

Moving on, we analyze the Generics Industry in Asia Pacific through the same parameters.

The Generics Industry in India is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter's Five Forces analysis of the Indian Generics Industry. Generics pricing and reimbursement situation in India and trends and challenges facing the industry are analyzed.

Analysis of the major industry players in the Indian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Cipla Limited, Lupin, Mylan, Sanofi SA, Teva Pharmaceutical Industries, Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd. and Sandoz International. This concludes this comprehensive research report from Aruvian Research.

Table of Contents

Table of Contents

A. Executive Summary

B. Analyzing the Global Generics Industry

  • B.1 Industry Definition
  • B.2 Industry Overview
  • B.3 Industry Value & Volume Analysis
  • B.4 Industry Segmentation by Geography
  • B.5 Patent Expiries
  • B.6 Global Generic Industry Structure
  • B.7 Industry Forecast

C. Generics Industry in Asia Pacific

  • C.1 Industry Overview
  • C.2 Industry Value & Volume
  • C.3 Industry Segmentation by Geography
  • C.4 Industry Forecast

D. Generics Industry in India

  • D.1 Industry Overview
  • D.2 Industry Value & Volume
  • D.3 Industry Segmentation by Geography
  • D.4 Industry Forecast

E. Generics Industry in India: Porter's Five Forces Strategy Analysis

  • E.1 Introduction
  • E.2 Bargaining Power of Buyers
  • E.3 Bargaining Power of Suppliers
  • E.4 Competitive Rivalry in the Industry
  • E.5 Threat of New Entrants
  • E.6 Threat of Substitutes

F. Pricing & Reimbursement in India

  • F.1 Overview
  • F.2 Generics Pricing & Reimbursement Scenario
  • F.3 Trends & Challenges

G. Major Industry Players

  • G.1 Cipla Limited
    • G.1.1 Corporate Analysis
    • G.1.2 Financial Analysis
    • G.1.3 SWOT Analysis
  • G.2 Lupin Limited
    • G.2.1 Corporate Analysis
    • G.2.2 Financial Analysis
    • G.2.3 SWOT Analysis
  • G.3 Mylan N.V.
    • G.3.1 Corporate Analysis
    • G.3.2 Financial Analysis
    • G.3.3 SWOT Analysis
  • G.4 Sanofi SA
    • G.4.1 Corporate Analysis
    • G.4.2 Financial Analysis
    • G.4.3 SWOT Analysis
  • G.5 Teva Pharmaceutical Industries Limited
    • G.5.1 Corporate Analysis
    • G.5.2 Financial Analysis
    • G.5.3 SWOT Analysis
  • G.6 Aurobindo Pharma Limited
  • G.7 Sandoz International GmbH
  • G.8 Sun Pharmaceutical Industries Ltd.

H. Glossary of Terms

List of Figures

  • Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
  • Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
  • Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
  • Figure 4: Global Generics Market Segmentation by Geography (%), 2016
  • Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
  • Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
  • Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
  • Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
  • Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
  • Figure 10: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
  • Figure 11: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
  • Figure 12: Share of the Asia Pacific Generics Industry by Countries (%), 2016
  • Figure 13: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
  • Figure 14: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
  • Figure 15: Value of the Generics Market in India (in USD Billion), 2012-2016
  • Figure 16: Volume Growth of the Generics Market in India (%), 2012-2016
  • Figure 17: Share of India in the Asia Pacific Generics Industry (%), 2016
  • Figure 18: Forecast of the Generics Market in India (in USD Billion), 2016-2021
  • Figure 19: Volume Forecast of the Generics Market in India (%), 2016-2021
  • Figure 20: Porter's Five Forces Strategy Analysis of the Generics Industry in India
  • Figure 21: Bargaining Power of Buyers in the Indian Generics Industry
  • Figure 22: Bargaining Power of Suppliers in the Indian Generics Industry
  • Figure 23: Competitive Rivalry in the Indian Generics Industry
  • Figure 24: Threat of New Entrants to the Indian Generics Industry
  • Figure 25: Threat of Substitutes to the Indian Generics Industry
  • Figure 26: Impacts on Drug Prices in India
  • Figure 27: Revenues & Profitability of Cipla Limited (in USD Million), 2011-2015
  • Figure 28: Revenues & Profitability of Lupin (in USD Million), 2011-2015
  • Figure 29: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
  • Figure 30: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015
  • Figure 31: Revenues & Profitability of Aurobindo Pharma (in USD Million), 2011-2015
  • Figure 32: Revenues & Profitability of Sun Pharmaceutical (in USD Million), 2011-2015

List of Tables

  • Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
  • Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
  • Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
  • Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
  • Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
  • Table 6: Value of the Asia Pacific Generics Market (in USD Billion), 2012-2016
  • Table 7: Volume Growth of the Asia Pacific Generics Market (%), 2012-2016
  • Table 8: Share of the Asia Pacific Generics Industry by Countries (% & USD Billion), 2016
  • Table 9: Forecast of the Asia Pacific Generics Market (in USD Billion), 2016-2021
  • Table 10: Volume Forecast of the Asia Pacific Generics Market (%), 2016-2021
  • Table 11: Value of the Generics Market in India (in USD Billion), 2012-2016
  • Table 12: Volume Growth of the Generics Market in India (%), 2012-2016
  • Table 13: Share of India in the Asia Pacific Generics Industry (in USD Billion & %), 2016
  • Table 14: Forecast of the Generics Market in India (in USD Billion), 2016-2021
  • Table 15: Volume Forecast of the Generics Market in India (%), 2016-2021
  • Table 16: Drug Prices in Jan Aushadhi Shops in India Compared to Market Prices
  • Table 17: Key Financials of Cipla Limited (in USD Million), 2011-2015
  • Table 18: Key Financials of Lupin (in USD Million), 2011-2015
  • Table 19: Key Financials of Sanofi SA (in USD Million), 2011-2015
  • Table 20: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015
  • Table 21: Key Financials of Aurobindo Pharma (in USD Million), 2011-2015
  • Table 22: Key Financials of Sun Pharmaceutical (in USD Million), 2011-2015
Back to Top